about
Adjuvants: Classification, Modus Operandi, and LicensingPlasmoSEP: Predicting surface-exposed proteins on the malaria parasite using semisupervised self-training and expert-annotated dataPlasmodium vivax Controlled Human Malaria Infection - Progress and ProspectsComplex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell AntigensAsia-Pacific malaria is singular, pervasive, diverse and invisibleNatural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.Efficacy of Phase 3 Trial of RTS, S/AS01 Malaria Vaccine in infants: a systematic review and meta-analysis.Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.Protective Vaccination against Blood-Stage Malaria of Plasmodium chabaudi: Differential Gene Expression in the Liver of Balb/c Mice toward the End of Crisis Phase.Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.Characterization of fine specificity of the immune response to a Plasmodium falciparum rhoptry neck protein, PfAARP.Differential miRNA Expression in the Liver of Balb/c Mice Protected by Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria.Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates.Experimental systems for studying Plasmodium/HIV coinfection.An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.Protective vaccination and blood-stage malaria modify DNA methylation of gene promoters in the liver of Balb/c mice.Kidney involvement in malaria: an update.Protective immunity differs between routes of administration of attenuated malaria parasites independent of parasite liver load.Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens.Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.Repetitive sequences in malaria parasite proteins.An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies.Enteroparasite and vivax malaria co-infection on the Brazil-French Guiana border: Epidemiological, haematological and immunological aspects.Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines.QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking Activities.The US Military Commitment to Vaccine Development: A Century of Successes and Challenges.Malaria
P2860
Q26747586-B4E4FB20-D9B5-4A37-880E-6A12AE973C6FQ27972840-DFE8519B-3BEE-4245-A302-E7586FCA6F7FQ28066456-16D3123F-573E-4AFF-B96B-39817F305E19Q28551311-E1A7816A-F75B-475E-92C6-368C4ADCE130Q33828552-0E9FE3B4-8F94-409D-B82D-ADB60613E6D8Q33834779-A1413FE1-AF3F-4597-9896-3B6C6D2D662DQ34548672-FA8AF767-D36F-4012-A7DC-789A6397558BQ36165265-8DCB7185-E407-4C68-AC27-3B89AEA8346DQ36178611-A58E1B02-A369-4910-A7DA-D1094AD575FCQ36790155-3E589A81-29B7-49B4-96E6-6AD560108A21Q37092616-40F7039C-C2AC-4637-954C-D05A6A9A3908Q37160241-AF400FEA-2A2D-4303-BF69-BEADE7DDFCE6Q37240166-C9920D92-C8A8-421C-B04A-0A11043643D3Q37578186-5D348862-3C27-4174-8493-9FF69C41013AQ38672088-DD64CC6D-6B67-4591-A31F-695932D5E381Q38786988-254E8027-85D2-423C-B68E-C60C686AB9F2Q38794455-017279EB-DE15-42AC-B14A-E6A8B2C6AB71Q38896857-2CBC2174-19E0-40A5-89DE-EA74403E383CQ39462997-970FFAC9-26CA-4384-BB24-F973D03E699AQ40067174-42BC955D-EF73-4582-88D7-B54C84FD16E0Q40120062-999B9D7C-5B07-4720-81F9-04F5020456CFQ40303478-8A1481E1-9114-4A37-8F47-1C72EFD0BA5CQ46273301-A80504BA-6800-4066-AD66-1FA0F4855F3AQ47150417-E3E10684-A419-4A06-8963-6330DC212D95Q48020555-91BBF1BD-99C3-4BE2-A7EF-3D3D4E47CEA1Q48021856-A2E3842A-228F-437B-A88E-539298ED4C95Q52645960-2DA81B9F-426A-49D6-B858-019276992FD0Q55432397-DA572FAF-D59C-47EF-B33A-7D3371FA5980Q56378965-F5420AEC-B47A-4ED6-81AB-A5743049205B
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The March Toward Malaria Vaccines
@ast
The March Toward Malaria Vaccines
@en
The March Toward Malaria Vaccines
@nl
type
label
The March Toward Malaria Vaccines
@ast
The March Toward Malaria Vaccines
@en
The March Toward Malaria Vaccines
@nl
prefLabel
The March Toward Malaria Vaccines
@ast
The March Toward Malaria Vaccines
@en
The March Toward Malaria Vaccines
@nl
P2860
P3181
P1476
The March Toward Malaria Vaccines
@en
P2093
Stephen L. Hoffman
Thomas L. Richie
P2860
P304
P3181
P356
10.1016/J.AMEPRE.2015.09.011
P407
P433
P577
2015-12-01T00:00:00Z